Submitted:
25 December 2024
Posted:
26 December 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
- How do IR short-term success rates compare following its initiation during periods of different risk levels as determined by FRIv2: low risk [green], moderate risk [yellow], or high-risk [red]?
2. Methods
- Improvement: at least a temporary improvement in FRIv2 score without a worsening of risk relative to onset of IR initiation over the six subsequent windows.
- Stabilization: no worsening in the level of risk relative to its level at IR initiation at the end of the sixth 20-minute window. Stabilization is a more inclusive category for success because it includes all cases of Improvement and also all other cases in which the risk level did not worsen by the end of the sixth window. Examples of IR response curves are shown in Figure 1. Cases that did not meet either criteria were considered failures.
3. Results
4. Discussion
- FRI Green Zone (score 1.0-0.625). Continued observation but withholding IR unless the fetus enters the Yellow Zone.
- FRI Yellow Zone (score 0.50-0.26). Initiate IR and compare subsequent scores in consecutive 20-minute windows for evidence of improvement or stabilization. Discontinue IR if fetus returns to the Green Zone or continue IR if there is stabilization.
- FRI Red Zone (0.25-0.0). Initiate IR with 20-minute window comparisons of score trajectory. Continue IR if fetus returns to Yellow Zone. Move to delivery if the fetus does not return to Yellow Zone within 40 minutes or if the score continues to decrease.
5. Strengths and Limitations
6. Conclusions
References
- Sanchez-Ramos L, Levine LD, Sciscione AC et al. Methods for the induction of labor: efficacy and safety. Am J Obstet Gynecol. Supplement to March 2024, 230:3S:S669-695). [CrossRef]
- Johnson K, Johanson K, Elvander C, Saltvedt S, Edqvist M. Variations in the use of oxytocin for augmentation of labour in Sweden: a population-based cohort study. Science Reports 2024:14(1):17483). [CrossRef]
- Hermesch AC, Kernberg AS, Layoun VR and Caughey AB. Oxytocin: physiology, pharmacology, and clinical application for labor management. Am J Obstet Gynecol. Supplement to March 2024, 230:3S:S729-739). [CrossRef]
- Garite TJ and Simpson KR. Intrauterine resuscitation during labor. Clinical Obstetrics and Gynecology. March 2011. 54(1):28-39 ). [CrossRef]
- Bullens LM, Heimel PJvR et al (2015). Interventions for intrauterine resuscitation in suspected fetal distress during term labor: a systematic review. Obstet Gynecol Surv 2015. 70(8):524-39.
- Reddy UM, Weiner SJ et al (2021). Intrapartum resuscitation interventions fdor category II fetal heart rate tracings and improvement to category I. Obstet Gynecol 2021. 138(3):409-416.
- Thayer SM, Faramarzi P et al (2023). Heterogeneity in management of category II fetal tracings: data from a multihospital healthcare system. American Journal of Obstetrics and Gynecology – Maternal Fetal Medicine. 2023; 5:01001. Epub 2023 May 3. [CrossRef]
- Verspyck E , Sentilhes L (2008). Pratiques obstétricales associées aux anomalies du rythme cardiaque fœtal (RCF) pendant le travail et mesures correctives à employer en cas d’anomalies du RCF pendant le travail. J Gynecol Obstet BioReprod 2008. 37(Suppl 1:S56-64).
- Evans MI, Britt DW, Evans M, Devoe LD. Improving the interpretation of electronic fetal monitoring: the fetal reserve index. Am J Obstet Gynecol November 2023;228:S1129-1143. [CrossRef]
- Goda M, Arakaki T et al Does maternal oxygen administration during non-reassuring fetal status affect the umbilical artery gas measures and neonatal outcomes? Arch Gynecol Obstet 2023;34:309993-1000.
- Moors S, Bullens LM et al (2020). The effect of intrauterine resuscitation by maternal hyperoxygenation on perinatal and maternal outcome: a randomized control trial. Am J Obstet Gynecol – Mat Fet Med 2020; 2:100-102. [CrossRef]
- Raghuraman N, Temming LA et al (2021). Maternal oxygen supplementation compared with room air for intrauterine resuscitation: a systematic review and meta-analysis. JAMA – Peds 2021;175:368-376. [CrossRef]
- Page K, McCool WF, Guidera M. Examination of the pharmacology of oxytocin and clinical guidelines for use in labor. J Midwif Womens Health 2017: 62:425-433. [CrossRef]
- Mondalou H, Yeh S-Y, Hon EH, Forsythe A (1973) Fetal and neonatal biochemistry and Apgar scores. Am J Obstet Gynecol 1973;117: 942-952.
- Mathews JNS, Douglas DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 1990;300:230-235.
- ACOG Practice Bulletin. Intrapartum fetal heart rate monitoring; nomenclature, interpretation, and general management principles. Number 106, July 2009 ACOG, Wash DC.
- Girault A, Goffinet F, Le Ray C. (2020) Reducing neonatal morbidity by discontinuing oxytocin during the active phase of first stage of labor: a multicenter randomized controlled trial STOPOXY. BMC Preg Childbirth. 2020; 20:640. [CrossRef]
- Jiang D, Yang Y, Zhang X, Nie X. Continued versus discontinued oxytocin after the active phase of labor: An updated systematic review and meta-analysis. PLoS One. 2022; 17: e0267461. [CrossRef]
- Boie S, Glavind J, Velu AV, Mol BWJ, Uldbjerg N, de Graaf I, Thornton JG, Bor P, Bakker JJ. CONDISOX- continued versus discontinued oxytocin stimulation of induced labour in a double-blind randomised controlled trial. BMC Pregnancy Childbirth 2019;19: 320.
- Saccone G, Ciardulli A et al. Discontinuing Oxytocin infusion in the active phase of labor: A systematic review and meta-analysis. Obstet Gynecol 2017. 130:1090-1096.
- Britt DW, Evans MI, Schifrin BS, Eden RD: Refining the prediction and prevention of emergency operative deliveries with the fetal reserve index. Fetal Diagn Ther 2019;46:159-165.
- Evans MI, Britt DW, Evans SM: Midforceps did not cause “compromised babies” – compromise caused forceps: an approach toward safely lowering the cesarean delivery rate. J Matern Fetal Neonat Med 2022;35:5265-5273.
- Evans MI, Britt DW, Devoe LD: Etiology and Ontogeny of Cerebral Palsy: implications for practice and research. Reprod Sci (in press). [CrossRef]
- Salwei ME, Carayon P (2022) A sociotechnical systems framework for the application of artificial intelligence in health care delivery. J Cogn Eng Decis Mak 2022. 16:194-206. PMID: 36704421.
- Gremyr A, Andersson Gäre B et al. The role of co-production in learning health systems. Int J Qual Health Care 2021. 33(Suppl_2):ii26-ii32.

| Variable |
Mean (SD) |
Percent |
| IR type Continued level of Pitocin Reduction in Pitocin Stopping of Pitocin |
33% 56% 11% |
|
| FRI grouping at start of IR Green (0.625 – 1.0) Yellow (0.375 – 0.500) Red (0.000 – 0.250) |
24% 46% 29% |
|
| Improvement No improvement Improvement |
28% 72% |
|
| Stabilization No stabilization Stabilization |
21% 79% |
|
| Total red zone minutes | 137.97 (238.43) |
|
Percentage Improved* (SD) |
Percentage Stabilized** (SD) |
|
| PIT Continuation (N=39) | 76% (44) |
78% (42) |
| PIT Reduction (N=64) | 75% (44) |
84% (37) |
| Pit Off (N=12) | 58% (52) |
67% (49) |
|
Percent Improved* (SD) |
Percent Stabilized** (SD) |
|
| Green (N=29) | 76% (44) |
89% (31) |
| Yellow (N=55) | 67% (47) |
75% (44) |
| Red (N=34) | 79% (41) |
79% (41) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).